Global Anticoagulation Therapy Market is Growing at a Significant Rate in the Forecast Period 2019-2026

According to Data Bridge Market Research new Market report, global anticoagulation therapy market accounted to USD 25.59 billion in 2018 growing at a CAGR of 8.01% during the forecast period of 2019 to 2026.

Global Anticoagulation Therapy Market

Global Anticoagulation Therapy Market

Anticoagulation therapy consists of the drugs and diagnostic methods that are focused on solving the problem of presence of blood clots. Blood clots formation occurs when proteins present in our bloods bind together forming a solid mass, these solid masses are known as blood clots which cause blockages in arteries and ultimately cause heart attacks or strokes. Anticoagulation drugs are aimed at impacting this clots formation and therefore prevent a number of heart attacks and strokes.

Access Full Report at https://databridgemarketresearch.com/reports/global-anticoagulation-therapy-market/

Segmentation: Global Anticoagulation Therapy Market

Global anticoagulation therapy market is segmented on the basis of drug class, product type, route of administration, application, distribution channel and geography.

By Drug Class (NOAC, Heparin, LMWH, Warfarin, Others), Product Type (Drugs, Testing, Service), Route of Administration (Oral, Injectable), Application (Cardiovascular Diseases, Coronary Artery Diseases, Cardiac Arrhythmia, Myocardial Infarction, DVT, Heart Valve Replacement), Distribution Channel (Hospitals, Clinics, Retail, Online), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

FACTORS DRIVING GROWTH IN ANTICOAGULATION THERAPY MARKET:

Rising Levels of Cardiovascular Diseases:

According to World Health Organization, cardiovascular diseases are the number one cause of deaths globally, causing more deaths than any other cause. Out of an estimated 56.9 million deaths cardiovascular diseases caused around an estimated 17.9 million deaths. Out of these cardiovascular disease deaths around 85% of it were due to heart attack and stroke. This number is expected to positively impact the demand of anticoagulation therapy as it solves the problem of stroke causing blood clots.

Global Anticoagulation Therapy Market

Global Anticoagulation Therapy Market

Key Market Competitors: Global Anticoagulation Therapy Market

Few of the major competitors currently working in the anticoagulation therapy market are Abbott., Baxter., AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Bristol-Myers Squibb Company, Merck & Co. Inc., Genentech Inc., GlaxoSmithKline plc., Pfizer Inc., Sanofi, Novartis AG, Aspen Holdings, DAIICHI SANKYO COMPANY LIMITED., Johnson & Johnson Services Inc., Portola Pharmaceuticals Inc., Siemens AG, CoaguSense Inc., and Mitsubishi Tanabe Pharma Corporation.

Browse Related Reports:

Global Hemophilia Treatment Market, By Product (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytic Agents), Type (Hemophilia A, Hemophilia B, Hemophilia C, Others), Therapy (On-Demand, Prophylaxis), Treatment (Replacement Therapy, ITI Therapy, Gene Therapy), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

https://databridgemarketresearch.com/reports/global-hemophilia-treatment-market/

Global Psoriasis Treatment Market, The Global Psoriasis Treatment Market is segmented By Application (Topical Therapeutic Drugs, Systemic Therapeutic Drugs, Combinations), By End – Users (Hospital Pharmacy, Clinics, Retail Pharmacies, Online Sales), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2025

https://databridgemarketresearch.com/reports/global-psoriasis-treatment-market/

Global Blood Plasma Market, By Type (Hyperimmune Globulin, Albumin, Factor VIII, Factor IX, Immunoglobulin,  Others), Application (Hypogammaglobulinemia, Immunodeficiency Diseases, Hemophilia, Von Willebrand’s Disease (vWD), Other Applications), End User (Hospitals, Clinics, Other End Users), Geography(North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2025

https://databridgemarketresearch.com/reports/global-blood-plasma-market/